Table 3.
Impact of Sex, Age, Tumor Stage, Tumor Grade, and Smoking History on RUNX3 Methylation (PMR ≥ 10%, N=304)
OR (95% CI) | p-value | |
---|---|---|
Age at Diagnosis | 0.0311 | |
1-Year Increase | 1.04 (1.00, 1.08) | |
Sex | 0.491 | |
Female | 1.00 (reference) | |
Male | 1.23 (0.68, 2.20) | |
Tumor Stage & Grade | 0.0101 | |
Ta - Low | 1.00 (reference) | |
Ta – High/CIS/T1 | 1.18 (0.68, 2.07) | |
T2+ | 2.16 (1.18, 3.94) | |
Smoking | 0.0151 | |
Never/Irregular | 1.00 (reference) | |
Former/Current | 2.76 (1.15, 6.66) |
p-value based on likelihood ratio test.